West Paces Advisors’s Twist Bioscience TWST Stock Holding History

West Paces Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-322	Closed	-$12.6K	–	532
2025 Q1	$12.6K	Hold	322	–	–	﹤0.01%	326
2024 Q4	$15K	Hold	322	–	–	﹤0.01%	319
2024 Q3	$14.5K	Hold	322	–	–	﹤0.01%	322
2024 Q2	$15.9K	Hold	322	–	–	﹤0.01%	310
2024 Q1	$11K	Hold	322	–	–	﹤0.01%	353
2023 Q4	$11.9K	Hold	322	–	–	﹤0.01%	346
2023 Q3	$6.52K	Hold	322	–	–	﹤0.01%	375
2023 Q2	$6.59K	Hold	322	–	–	﹤0.01%	399
2023 Q1	$4.86K	Hold	322	–	–	﹤0.01%	429
2022 Q4	$7.67K	Hold	322	–	–	﹤0.01%	374
2022 Q3	$11.3K	Hold	322	–	–	﹤0.01%	337
2022 Q2	$11.3K	Hold	322	–	–	﹤0.01%	359
2022 Q1	$15.9K	Hold	322	–	–	0.01%	332
2021 Q4	$24.9K	Hold	322	–	–	0.01%	290
2021 Q3	$34.4K	Hold	322	–	–	0.01%	241
2021 Q2	$42.9K	Hold	322	–	–	0.02%	218
2021 Q1	$39.9K	Buy	+322	New	+$48.9K	0.02%	210

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

West Paces Advisors's TWST Position: Q2 2025 in Review

West Paces Advisors sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 322 shares — an estimated $12.6K sold.

West Paces Advisors first reported a position in TWST in Q1 2021 and held it in 17 quarters. The position peaked at $42.9K in Q2 2021. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

West Paces Advisors reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
West Paces Advisors sold 322 Twist Bioscience shares in Q2 2025, an estimated $12.6K.
West Paces Advisors first reported a position in Twist Bioscience in Q1 2021 and held it in 17 quarters.
West Paces Advisors's Twist Bioscience position peaked at $42.9K in Q2 2021.
243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on West Paces Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.